5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
BUY | BUY | BUY | BUY | BUY |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 1.61▲ | 1.61▲ | 1.60▲ | 1.60▲ | 1.61▼ |
MA10 | 1.61▲ | 1.61▲ | 1.60▲ | 1.60▲ | 1.68▼ |
MA20 | 1.60▲ | 1.60▲ | 1.60▲ | 1.60▼ | 1.49▲ |
MA50 | 1.60▲ | 1.61▼ | 1.61▲ | 1.68▼ | 1.49▲ |
MA100 | 1.61▲ | 1.60▲ | 1.60▲ | 1.43▲ | 1.23▲ |
MA200 | 1.60▲ | 1.61▲ | 1.63▼ | 1.50▲ | N/A |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | 0.001▲ | 0.001▲ | 0.001▲ | 0.002▲ | -0.001▼ |
RSI | 55.623▲ | 52.515▲ | 51.482▲ | 47.890▼ | 54.037▲ |
STOCH | 83.333▲ | 76.667 | 57.143 | 57.752 | 32.494 |
WILL %R | 0.000▲ | 0.000▲ | -28.571 | -35.300 | -59.211 |
CCI | 75.969 | 83.142 | 96.667 | 27.045 | -30.061 |
CDL | $QNCX Doji Candlestick Pattern Detected | Set Alert |
Thursday, September 11, 2025 01:23 PM
Quince Therapeutics, Inc. (Nasdaq: QNCX), a late-stage biotechnology company dedicated to unlocking the power of a patient’s own biology for the treatment of rare diseases, today announced that it ...
|
Tuesday, September 02, 2025 01:19 PM
Quince Therapeutics, Inc. (Nasdaq: QNCX), a late-stage biotechnology company dedicated to unlocking the power of a patient’s own biology for the treatment of rare diseases, today announced that Dirk ...
|
Saturday, August 09, 2025 08:12 AM
Detailed price information for Option Care Health Inc (OPCH-Q) from The Globe and Mail including charting and trades.
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
15/09/25 | 1.60 | 1.62 | 1.58 | 1.60 | 88,479 |
12/09/25 | 1.58 | 1.62 | 1.58 | 1.60 | 133,052 |
11/09/25 | 1.61 | 1.67 | 1.56 | 1.58 | 222,267 |
10/09/25 | 1.61 | 1.67 | 1.61 | 1.61 | 120,760 |
09/09/25 | 1.56 | 1.6568 | 1.56 | 1.61 | 139,081 |
08/09/25 | 1.59 | 1.62 | 1.57 | 1.57 | 127,622 |
05/09/25 | 1.60 | 1.6298 | 1.57 | 1.61 | 88,853 |
04/09/25 | 1.58 | 1.65 | 1.57 | 1.605 | 134,170 |
03/09/25 | 1.57 | 1.62 | 1.54 | 1.61 | 72,607 |
02/09/25 | 1.63 | 1.63 | 1.54 | 1.60 | 65,621 |
|
|
||||
|
|
||||
|
|